Literature DB >> 20534476

Crystal structure of soluble MD-1 and its interaction with lipid IVa.

Sung-il Yoon1, Minsun Hong, Gye Won Han, Ian A Wilson.   

Abstract

Lipopolysaccharide (LPS) of Gram-negative bacteria is a common pathogen-associated molecular pattern (PAMP) that induces potent innate immune responses. The host immune response against LPS is triggered by myeloid differentiation factor 2 (MD-2) in association with Toll-like receptor 4 (TLR4) on the cell surface. The MD-2/TLR4-mediated LPS response is regulated by the evolutionarily related complex of MD-1 and Toll-like receptor homolog RP105. Here, we report crystallographic and biophysical data that demonstrate a previously unidentified direct interaction of MD-1 with LPS. The crystal structure of chicken MD-1 (cMD-1) at 2.0 A resolution exhibits a beta-cup-like fold, similar to MD-2, that encloses a hydrophobic cavity between the two beta-sheets. A lipid-like moiety was observed inside the cavity, suggesting the possibility of a direct MD-1/LPS interaction. LPS was subsequently identified as an MD-1 ligand by native gel electrophoresis and gel filtration analyses. The crystal structure of cMD-1 with lipid IVa, an LPS precursor, at 2.4 A resolution revealed that the lipid inserts into the deep hydrophobic cavity of the beta-cup-like structure, but with some important differences compared with MD-2. These findings suggest that soluble MD-1 alone, in addition to its complex with RP105, can regulate host LPS sensitivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534476      PMCID: PMC2890730          DOI: 10.1073/pnas.1004153107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.

Authors:  Norihito Yazawa; Manabu Fujimoto; Shinichi Sato; Kensuke Miyake; Noriko Asano; Yoshinori Nagai; Osamu Takeuchi; Kiyoshi Takeda; Hitoshi Okochi; Shizuo Akira; Thomas F Tedder; Kunihiko Tamaki
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

Review 3.  Innate immune sensing and its roots: the story of endotoxin.

Authors:  Bruce Beutler; Ernst Th Rietschel
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

4.  Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4.

Authors:  A Visintin; A Mazzoni; J A Spitzer; D M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

5.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

6.  MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.

Authors:  Jianmin Meng; Egil Lien; Douglas T Golenbock
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

Review 7.  ML -- a conserved domain involved in innate immunity and lipid metabolism.

Authors:  Naohiro Inohara; Gabriel Nuñez
Journal:  Trends Biochem Sci       Date:  2002-05       Impact factor: 13.807

8.  Essential role of MD-2 in LPS responsiveness and TLR4 distribution.

Authors:  Yoshinori Nagai; Sachiko Akashi; Masakazu Nagafuku; Masato Ogata; Yoichiro Iwakura; Shizuo Akira; Toshio Kitamura; Atsushi Kosugi; Masao Kimoto; Kensuke Miyake
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

9.  Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice.

Authors:  Sima Hadidi; Zhiqi Chen; Jim Phillips; Kai Yu; Reginald M Gorczynski
Journal:  Transplantation       Date:  2002-06-15       Impact factor: 4.939

10.  Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease.

Authors:  Natalia Friedland; Heng-Ling Liou; Peter Lobel; Ann M Stock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

View more
  17 in total

1.  Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues.

Authors:  Gary D Ainge; William John Martin; Benjamin J Compton; Colin M Hayman; David S Larsen; Sung-Il Yoon; Ian A Wilson; Jacquie L Harper; Gavin F Painter
Journal:  J Med Chem       Date:  2011-10-05       Impact factor: 7.446

2.  Insights into substrate specificity of geranylgeranyl reductases revealed by the structure of digeranylgeranylglycerophospholipid reductase, an essential enzyme in the biosynthesis of archaeal membrane lipids.

Authors:  Qingping Xu; Tadashi Eguchi; Irimpan I Mathews; Christopher L Rife; Hsiu-Ju Chiu; Carol L Farr; Julie Feuerhelm; Lukasz Jaroszewski; Heath E Klock; Mark W Knuth; Mitchell D Miller; Dana Weekes; Marc-André Elsliger; Ashley M Deacon; Adam Godzik; Scott A Lesley; Ian A Wilson
Journal:  J Mol Biol       Date:  2010-10-01       Impact factor: 5.469

3.  Structural basis of lipid binding for the membrane-embedded tetraacyldisaccharide-1-phosphate 4'-kinase LpxK.

Authors:  Ryan P Emptage; Nam K Tonthat; John D York; Maria A Schumacher; Pei Zhou
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

Review 4.  The structural biology of Toll-like receptors.

Authors:  Istvan Botos; David M Segal; David R Davies
Journal:  Structure       Date:  2011-04-13       Impact factor: 5.006

5.  Inflammatory caspases are innate immune receptors for intracellular LPS.

Authors:  Jianjin Shi; Yue Zhao; Yupeng Wang; Wenqing Gao; Jingjin Ding; Peng Li; Liyan Hu; Feng Shao
Journal:  Nature       Date:  2014-08-06       Impact factor: 49.962

6.  An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1.

Authors:  Sung-il Yoon; Minsun Hong; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2011-08-21       Impact factor: 15.369

7.  Recombinant expression of TLR5 proteins by ligand supplementation and a leucine-rich repeat hybrid technique.

Authors:  Minsun Hong; Sung-Il Yoon; Ian A Wilson
Journal:  Biochem Biophys Res Commun       Date:  2012-09-16       Impact factor: 3.575

8.  Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids.

Authors:  Maximiliano J Jiménez-Dalmaroni; Catherine M Radcliffe; David J Harvey; Mark R Wormald; Petra Verdino; Gary D Ainge; David S Larsen; Gavin F Painter; Richard Ulevitch; Bruce Beutler; Pauline M Rudd; Raymond A Dwek; Ian A Wilson
Journal:  Innate Immun       Date:  2014-03-03       Impact factor: 2.680

9.  The TLR4 antagonist Eritoran protects mice from lethal influenza infection.

Authors:  Kari Ann Shirey; Wendy Lai; Alison J Scott; Michael Lipsky; Pragnesh Mistry; Lioubov M Pletneva; Christopher L Karp; Jaclyn McAlees; Theresa L Gioannini; Jerrold Weiss; Wilbur H Chen; Robert K Ernst; Daniel P Rossignol; Fabian Gusovsky; Jorge C G Blanco; Stefanie N Vogel
Journal:  Nature       Date:  2013-05-01       Impact factor: 49.962

10.  LPS ligand and culture additives improve production of monomeric MD-1 and 2 in Pichia pastoris by decreasing aggregation and intermolecular disulfide bonding.

Authors:  Kristen E Mengwasser; Clare E Bryant; Nick J Gay; Monique Gangloff
Journal:  Protein Expr Purif       Date:  2010-12-02       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.